Bio-Rad Laboratories, Inc. Class A Common Stock vs Jabil Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while Jabil Inc trades at $360.5 (market cap $37.37B). The key difference: Jabil Inc is far larger — about 4× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Jabil Inc pays a 0.09% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | JBL | |
|---|---|---|
Market Cap | $9.43B | $37.37B |
Sector | Health | Technology |
52-Week High | $356.25 | $385.50 |
52-Week Low | $241.71 | $192.49 |
Enterprise Value | $9.18B | $39.90B |
Dividend Yield | — | 0.09% |
Trailing returns across standard periods
Latest headlines on both assets
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →